![Christopher Brennan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Christopher S.
Brennan is currently the Chief Operating Officer at Allucent.
Cargos activos de Christopher Brennan
Empresas | Cargo | Inicio |
---|---|---|
Allucent
![]() Allucent Pharmaceuticals: OtherHealth Technology Allucent is a clinical research organization that provides comprehensive drug development solutions to small and mid-sized biotech companies. The private company is based in Cary, NC, and was founded in 2022. With over 30 years of experience in more than 60 countries, the company offers consulting, clinical operations, biometrics, and clinical pharmacology services across various therapeutic areas. Allucent's individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients. Mark A. Goldberg has been the CEO of the company since 2018. | Director de Operaciones | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Allucent
![]() Allucent Pharmaceuticals: OtherHealth Technology Allucent is a clinical research organization that provides comprehensive drug development solutions to small and mid-sized biotech companies. The private company is based in Cary, NC, and was founded in 2022. With over 30 years of experience in more than 60 countries, the company offers consulting, clinical operations, biometrics, and clinical pharmacology services across various therapeutic areas. Allucent's individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients. Mark A. Goldberg has been the CEO of the company since 2018. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Brennan